Jeudi, 21 Septembre 2017
Dernières nouvelles
Principale » Cigna Corporation (NYSE:CI) Trading Volume Significantly Higher

Cigna Corporation (NYSE:CI) Trading Volume Significantly Higher

17 Septembre 2017

They now have a $191.00 target price on the health services provider's stock. Toronto Dominion Bank grew its stake in shares of Cigna Corporation by 25.0% in the 2nd quarter. Bacus Lisa R also sold $1.85 million worth of CIGNA Corporation (NYSE:CI) shares. LLC increased its holdings in Cigna Corporation by 2.8% in the second quarter. Profund Advisors LLC now owns 10,646 shares of the health services provider's stock worth $1,782,000 after purchasing an additional 287 shares during the last quarter. Founders Capital Management bought a new position in Cigna Corporation in the 1st quarter valued at $117,000. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.48 by $0.43. Parallel Advisors LLC now owns 800 shares of the health services provider's stock worth $139,000 after purchasing an additional 307 shares during the period. Finally, Dynamic Technology Lab Private Ltd increased its holdings in Cigna Corporation by 255.4% in the second quarter. Toronto Dominion Bank now owns 86,740 shares of the health services provider's stock valued at $14,517,000 after purchasing an additional 17,348 shares during the period. Following the completion of the transaction, the chief executive officer now directly owns 421,162 shares of the company's stock, valued at $71,681,772.40. About 2.46M shares traded or 98.39% up from the average. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $188.36. Company chares are trading at $186.05 which is just a bit higher than the 50 day moving average of $179.52 and a great deal higher than the 200 day moving average of $165.10. The firm has a market capitalization of $46.84 billion, a PE ratio of 21.47 and a beta of 0.43. Haverford Tru holds 0.06% of its portfolio in CIGNA Corporation (NYSE:CI) for 20,052 shares. Analysts expect next quarter's EPS to be $2.03 with next year's EPS anticipated to be $11.35. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. Cigna Corporation's revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts forecast that Cigna Corporation will post $10.02 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: "Cigna Corporation (CI) Receives Average Recommendation of "Buy" from Analysts" was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this article on another domain, it was copied illegally and reposted in violation of US and worldwide trademark & copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2017/09/17/cigna-corporation-ci-shares-sold-by-howard-hughes-medical-institute.html.

These firms have modified their investment in CI.

August 7 investment analysts at Deutsche Bank maintained a stock rating of "Overweight" and raised the price target from $180.00 to $188.00. ValuEngine upgraded Cigna Corporation from a "hold" rating to a "buy" rating in a research note on Friday, June 2nd. The stock of CIGNA Corporation (NYSE:CI) earned "Buy" rating by Citigroup on Friday, October 2. The stock of MYR Group Inc (NASDAQ:MYRG) has "Buy" rating given on Tuesday, August 11 by Zacks. If the $195.35 price target is reached, the company will be worth $2.34B more.

Al Hoceima : Le Maroc tire à boulets rouges sur HRW
Cette dernière estime que le contenu du rapport vise notamment à discréditer les efforts du Maroc en matière des droits de l'Homme.

In other news, CEO David Cordani sold 153,168 shares of Cigna Corporation stock in a transaction dated Monday, June 19th. The total value of its holdings decreased 42.1%. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William D. Zollars sold 1,232 shares of the stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The disclosure for this sale can be found here.

The Shareholder Yield is a way that investors can see how much money shareholders are receiving from a company through a combination of dividends, share repurchases and debt reduction. Another trade for 275 shares valued at $9,349 was made by Johnson Betty R. on Monday, May 8.

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company, through its subsidiaries, operates offshore supply vessels, multi-purpose support vessels (MPSVs), and a shore-base facility to provide logistics support and specialty services to the offshore gas and oil exploration and production industry, primarily in the United States, Gulf of Mexico, Latin America and selected worldwide markets. The Business's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.